BRILINTA-90MG-14 TABLETS (Ticagrelor 90 mg) Antiplatelet Tablets
BRILINTA-90MG-14 TABLETS contain Ticagrelor 90 mg, a prescription antiplatelet medicine that helps reduce the risk of heart attack, stroke, and blood clot formation in eligible cardiovascular patients.
BRILINTA-90MG-14 TABLETS
BRILINTA-90MG-14 TABLETS (Ticagrelor 90 mg): Comprehensive Guide and Benefits
Introduction to BRILINTA-90MG-14 TABLETS (Ticagrelor 90 mg)
BRILINTA-90MG-14 TABLETS (Ticagrelor 90 mg): A P2Y12 Antiplatelet Medication
BRILINTA-90MG-14 TABLETS are a prescription-only antiplatelet medicine containing Ticagrelor 90 mg. Ticagrelor belongs to the P2Y12 platelet receptor inhibitor class and is used to reduce the risk of blood clot formation in patients with acute coronary syndrome (ACS), recent heart attack, or certain other cardiovascular conditions. It is commonly prescribed together with low-dose aspirin unless contraindicated.
Ticagrelor works by preventing platelets from sticking together, reducing the likelihood of clots that can block blood vessels and cause heart attacks or strokes. Because it increases bleeding risk, treatment should be supervised by a qualified healthcare professional. Patients should not discontinue the medicine without medical advice, as doing so may increase the risk of serious cardiovascular events.
Key Benefits of BRILINTA-90MG-14 TABLETS (Ticagrelor 90 mg)
Helps reduce the risk of heart attack and stroke.
Prevents harmful blood clot formation in high-risk cardiovascular patients.
Reduces the risk of stent thrombosis following coronary stent placement.
Provides rapid and reversible platelet inhibition.
Commonly used alongside low-dose aspirin for dual antiplatelet therapy.
How BRILINTA-90MG-14 TABLETS (Ticagrelor 90 mg) Works
Ticagrelor is a direct-acting, reversible P2Y12 adenosine diphosphate (ADP) receptor antagonist. By blocking P2Y12 receptors on platelets, it inhibits platelet activation and aggregation, reducing thrombus formation within arteries. Unlike some other antiplatelet medicines, ticagrelor does not require metabolic activation, allowing for rapid onset of action and effective platelet inhibition.
Usage Instructions for BRILINTA-90MG-14 TABLETS
Take exactly as prescribed by your healthcare provider.
Swallow the tablet whole with water, with or without food.
Take the medicine at the same times each day, typically twice daily unless otherwise directed.
Continue low-dose aspirin only as instructed by your healthcare provider.
Attend regular follow-up visits to monitor bleeding risk and treatment effectiveness.
Medicinal Advantages of BRILINTA-90MG-14 TABLETS
Proven to reduce major cardiovascular events in eligible patients.
Provides effective platelet inhibition with rapid onset.
Helps prevent recurrent heart attack and ischemic stroke.
Reduces the risk of blood clots after coronary stent placement.
Supported by extensive clinical evidence in cardiovascular medicine.
NOTE: BRILINTA-90MG-14 TABLETS are prescription-only medicines. They should not be used in patients with active bleeding or a history of intracranial hemorrhage. Do not discontinue therapy without medical advice, as this may increase the risk of cardiovascular events.
Off-Label Uses of BRILINTA-90MG-14 TABLETS
Healthcare professionals may occasionally prescribe ticagrelor for selected cardiovascular conditions based on current clinical evidence and individual patient assessment.
Selected high-risk coronary artery disease management.
Specialist-directed prevention of thrombotic complications.
Individualized antiplatelet strategies in complex cardiovascular patients.
Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.
Expert Advice for Optimal Use
Take every dose exactly as prescribed without missing doses.
Do not stop treatment without consulting your cardiologist.
Inform all healthcare providers before surgery or dental procedures.
Watch for unusual bruising or prolonged bleeding.
Avoid over-the-counter NSAIDs unless approved by your doctor.
Carry a list of your medications in case of emergencies.
Precautions
Cardiovascular Health
Continue therapy exactly as prescribed. Premature discontinuation may significantly increase the risk of heart attack, stroke, or stent thrombosis.
Liver & Kidney Function
Use cautiously in patients with severe liver impairment. Routine clinical monitoring may be appropriate depending on the patient's medical condition.
Pregnancy & Breastfeeding
Use during pregnancy or breastfeeding only if the expected benefits outweigh the potential risks and under medical supervision.
Drug Interactions
Ticagrelor may interact with strong CYP3A inhibitors, CYP3A inducers, anticoagulants, NSAIDs, digoxin, and other medicines that increase bleeding risk. Always inform your healthcare provider about all prescription medicines, supplements, and herbal products you use.
Existing Medical Conditions
Inform your healthcare provider if you have active bleeding, stomach ulcers, liver disease, asthma, previous stroke, bleeding disorders, or require surgery.
Storage Instructions
Store below 30°C.
Keep the tablets in the original blister pack.
Protect from moisture and direct sunlight.
Keep out of the reach of children.
Do not use after the expiry date.
Frequently Asked Questions (FAQs)
Q: What is BRILINTA-90MG-14 TABLETS used for?
A: It is used to reduce the risk of heart attack, stroke, and blood clot formation in eligible patients with acute coronary syndrome or other cardiovascular conditions.
Q: What is the active ingredient in BRILINTA-90MG-14 TABLETS?
A: Each tablet contains Ticagrelor 90 mg, a P2Y12 antiplatelet medicine.
Q: Should BRILINTA be taken with aspirin?
A: In many patients, ticagrelor is prescribed together with low-dose aspirin unless there is a contraindication. Follow your healthcare provider's instructions.
Q: What are the common side effects?
A: Common side effects include bleeding, bruising, shortness of breath (dyspnea), nosebleeds, and gastrointestinal discomfort. Seek immediate medical attention for severe or uncontrolled bleeding.
Q: Can I stop taking BRILINTA on my own?
A: No. Stopping treatment without medical advice may increase the risk of heart attack, stroke, or stent thrombosis.
Q: Can I take painkillers while using BRILINTA?
A: Some pain relievers, particularly NSAIDs, may increase bleeding risk. Consult your healthcare provider before taking any new medication.
Q: Is BRILINTA-90MG-14 TABLETS available without a prescription?
A: No. It is a prescription-only medicine and should be used only under the supervision of a qualified healthcare professional.
Product Tags
BRILINTA-90MG-14 TABLETS, Ticagrelor 90 mg, Ticagrelor Tablet, P2Y12 Inhibitor, Antiplatelet Medicine, Blood Thinner Tablet, Acute Coronary Syndrome Treatment, Heart Attack Prevention, Stroke Prevention, Stent Thrombosis Prevention, Cardiovascular Medicine, Dual Antiplatelet Therapy, Prescription Antiplatelet, Platelet Aggregation Inhibitor, Coronary Artery Disease Medicine, ACS Treatment, Ticagrelor Prescription, BRILINTA Tablet, Heart Disease Medication, Blood Clot Prevention
